Fulcrum Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
FULC Nasdaq 2836 www.fulcrumtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics (FULC) Upgraded to Buy: Here's Why - Nov 28th, 2024 5:00 pm
Fulcrum Therapeutics to Participate in Upcoming December Conferences - Nov 26th, 2024 9:05 pm
Fulcrum Therapeutics Third Quarter 2024 Earnings: US$0.35 loss per share (vs US$0.39 loss in 3Q 2023) - Nov 15th, 2024 12:28 pm
Fulcrum Therapeutics Inc (FULC) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst ... - Nov 14th, 2024 7:07 am
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024 - Nov 13th, 2024 12:00 pm
Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference - Nov 12th, 2024 9:05 pm
Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET - Nov 6th, 2024 1:00 pm
Fulcrum Before Q3 Earnings: How Should Investors Play the Stock? - Oct 25th, 2024 1:55 pm
We're Interested To See How Fulcrum Therapeutics (NASDAQ:FULC) Uses Its Cash Hoard To Grow - Oct 21st, 2024 2:07 pm
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up - Oct 18th, 2024 12:00 pm
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 11th, 2024 8:30 pm
Fulcrum Therapeutics Inc (FULC) Q2 2024 Earnings Call Highlights: Strong Financial Performance ... - Oct 9th, 2024 7:30 pm
Fulcrum Stock Tanks 58% in a Month: Buying Opportunity or Risky Bet? - Oct 9th, 2024 3:31 pm
FMR LLC's Strategic Reduction in Fulcrum Therapeutics Inc Shares - Oct 7th, 2024 7:02 pm
Down -57.53% in 4 Weeks, Here's Why Fulcrum Therapeutics (FULC) Looks Ripe for a Turnaround - Oct 4th, 2024 1:35 pm
RA Capital Management's Strategic Acquisition of Fulcrum Therapeutics Shares - Sep 17th, 2024 5:30 am
Fulcrum Therapeutics (FULC) Loses -65.58% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Sep 16th, 2024 1:35 pm
FULC Stock Falls as Muscle Disorder Study Misses Primary Goal - Sep 13th, 2024 3:07 pm
Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial - Sep 12th, 2024 3:32 pm
Fulcrum shares collapse as Sanofi-partnered muscular dystrophy drug fails key test - Sep 12th, 2024 12:10 pm